Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Large-Scale Post-Transplant TCR Deep Sequencing Reveals a Major T Cell Diversity Bottleneck with Post-Transplant Cyclophosphamide with Implications for Both Efficacy and Toxicity: Results of the BMT CTN 1801 Study

Blood (2023) 142 (Supplement 1): 475.

https://doi.org/10.1182/blood-2023-188032

Published: 2023

Journal Articles

Molecular Detection of Minimal Residual Disease Precedes Morphological Relapse and Could be Used to Identify Relapse in Pediatric and Young Adult B-Cell Acute Lymphoblastic Leukemia Patients Treated with Tisagenlecleucel

Blood (2018) 132 (Supplement 1): 1551.

https://doi.org/10.1182/blood-2018-99-115460

Published: 2018

Journal Articles

Measurable residual disease detection by high-throughput sequencing improves risk stratification for pediatric B-ALL

Brent Wood, David Wu, Beryl Crossley, Yunfeng Dai, David Williamson, Charles Gawad, Michael J. Borowitz, Meenakshi Devidas, Kelly W. Maloney, Eric Larsen, Naomi Winick, Elizabeth Raetz, William L. Carroll, Stephen P. Hunger, Mignon L. Loh, Harlan Robins, Ilan Kirsch

Blood (2018) 131 (12): 1350–1359.

https://doi.org/10.1182/blood-2017-09-806521

Published: 2018

Includes: Supplemental data

Journal Articles

Day 90 Post-Allogeneic Hematopoietic Cell Transplantation T Cell Receptor Diversity Level Correlates with Risk of Relapse in Patients with Multiple Myeloma

Robert Korngold, PhD, Kira Goldgirsh, MS, Themba Nyirenda, PhD, Phyllis McKiernan, APN, MSN, Ryan Emerson, PhD, Marissa Vignali, PhD, Julie Rubinstein, Harlan Robins, PhD, David Siegel, MD PhD, Michele L. Donato, MD

Blood (2017) 130 (Supplement 1): 4506.

https://doi.org/10.1182/blood.V130.Suppl_1.4506.4506

Published: 2017

Journal Articles

Residual Disease Monitoring By High Throughput Sequencing Provides Risk Stratification in Childhood B-ALL and Identifies a Novel Subset of Patients Having Poor Outcome

Brent L. Wood, MD PhD, David Wu, MD PhD, Ilan M. Kirsch, MD, Beryl Crossley, BS, David Williamson, Charles Gawad, MD, Michael J. Borowitz, MD PhD, Meenakshi Devidas, PhD, Kelly W. Maloney, MD, Eric Larsen, MD, Naomi Winick, MD, Elizabeth Raetz, MD, William L. Carroll, MD, Stephen P. Hunger, MD, Mignon L. Loh, MD, Harlan Robins, PhD

Blood (2016) 128 (22): 1086.

https://doi.org/10.1182/blood.V128.22.1086.1086

Published: 2016

Journal Articles

Integrated Immunological Analysis of the Bone Marrow Tumor Microenvironment in Myeloproliferative Neoplasms to Determine Potential Efficacy of Immune Checkpoint Blockade

Robert Orlowski, MD, Alexander Huang, Mercy Gohil, James Mangan, MD PhD, Marissa Vignali, PhD, Ryan O Emerson, PhD, Harlan Robins, PhD, Erik Yusko, PhD, Martha S Jordan, PhD, Martin Carroll, MD, D. Gary Gilliland, MD PhD, Elizabeth O Hexner, MD

Blood (2015) 126 (23): 2766.

https://doi.org/10.1182/blood.V126.23.2766.2766

Published: 2015

Journal Articles

A Complementary Role of High Throughput Sequencing and Multiparameter Cytometry for Minimal Residual Disease (MRD) Detection in Chronic Lymphocytic Leukemia (CLL):an European Research Initiative (ERIC) Study

Andy Rawstron, PhD, Claudia Fazi, PhD, Neus Villamor, MD PhD, Julio Delgado, MD PhD, Remi Letestu, MD PhD, Florence Cymbalista, MD, Carlos Palacio, Francesc Bosch, MD PhD, Ruth M De Tute, MSc, Stuart Liptrot, David O'Brien, FAMLs, Martin Spacek, MD, PhD, Johan Dobber, Arnon P. Kater, MD PhD, Peter C Gambell, David A Westerman, MBBS, FRACP, FRCPA, Asha Soosapilla, Stephen P. Mulligan, MBBS, PhD FRACP, FRCPA, Gerard Lozanski, MD, Ke Lin, PhD, Andrew R Pettitt, MRCP, PhD, Gabi Brachtl, Alexander Egle, MD, David W Williamson, PhD, Catherine M Sanders, PhD, Harlan Robins, PhD, Justin Boysen, Tait D. Shanafelt, MD, Curtis A. Hanson, MD, Jeffrey L. Jorgensen, MD PhD, William G. Wierda, MD PhD, Constance Yuan, MD PhD, Maryalice Stetler-Stevenson, MD PhD, Laura Rassenti, PhD, H. Elizabeth Broome, MD, Thomas J. Kipps, MD PhD, Mathieu Hauwel, Iuri Marinov, Fiona E. Craig, MBBS, Nomdedeu Josep, Carol Moreno, MD, Olga Stehlikova, MSc., Michael Doubek, Sarka Pospisilova, Prof., Dr., PhD, Karl-Anton Kreuzer, MD, Michael Hallek, MD, Peter Hillmen, MBChB, PhD, Emili Montserrat, MD PhD, Paolo Ghia, MD

Blood (2014) 124 (21): 1976.

https://doi.org/10.1182/blood.V124.21.1976.1976

Published: 2014

Journal Articles

Minimal Residual Disease Detection By Next Generation Sequencing in Adult B-Cell Acute Lymphoblastic Leukemia (ALL) Patients Treated on SWOG Trial S0333

Olga Sala Torra, MD, Megan Othus, PhD, David W Williamson, PhD, Brent L. Wood, MD PhD, Ilan Kirsch, MD, Harlan Robins, PhD, Margaret O'Donnell, Stephen J. Forman, Frederick R. Appelbaum, MD, Jerald P Radich, MD

Blood (2014) 124 (21): 2399.

https://doi.org/10.1182/blood.V124.21.2399.2399

Published: 2014

Journal Articles

High Throughput TCR Sequencing Provides Added Value in the Diagnosis of Cutaneous T-Cell Lymphoma

Ilan Kirsch, MD, David W Williamson, PhD, James Krueger, MD PhD, Jessica Teague, PhD, Christopher Elco, MD PhD, Harlan Robins, PhD, Thomas S. Kupper, MD, Rachael A Clark, MDPhD

Blood (2014) 124 (21): 1683.

https://doi.org/10.1182/blood.V124.21.1683.1683

Published: 2014

Journal Articles

TCR Repertoire Diversity Assessed with Immunosequencing Is Associated with Patient Mortality Following Cord Blood Transplant

Ryan O Emerson, PhD, Sarah Nikiforow, MD PhD, Filippo Milano, MD PhD, Anna M Sherwood, PhD, Adrienne Papermaster, Katherine A. Guthrie, PhD, Christopher S Carlson, PhD, Edus H. Warren, MD PhD, Jerome Ritz, MD, Harlan Robins, PhD, Corey S Cutler, MD MPH, Colleen Delaney, MD

Blood (2014) 124 (21): 1262.

https://doi.org/10.1182/blood.V124.21.1262.1262

Published: 2014

Journal Articles

Robust Detection Of Minimal Residual Disease In Unselected Patients With B-Cell Precursor Acute Lymphoblastic Leukemia By High-Throughput Sequencing Of IGH

David Wu, MD, PhD, Ryan O Emerson, PhD, Anna Sherwood, PhD, Mignon L. Loh, MD, Anne Angiolillo, MD, Ilan Kirsch, MD, Christopher S Carlson, PhD, David Williamson, PhD, Brent L. Wood, MD, PhD, Harlan Robins, PhD

Blood (2013) 122 (21): 2550.

https://doi.org/10.1182/blood.V122.21.2550.2550

Published: 2013

Journal Articles

Reduction Of Immune Repertoire Diversity Through DNA Sequence Constraints At VDJ Junctions

Bryan Howie, PhD, Harlan Robins, PhD, Christopher S Carlson, PhD

Blood (2013) 122 (21): 4944.

https://doi.org/10.1182/blood.V122.21.4944.4944

Published: 2013

Journal Articles

Annotation Of Pseudogenous Gene Segments By Massively Parallel Sequencing Of Rearranged Lymphocyte Receptor Loci

Ryan O Emerson, PhD, Anna Sherwood, PhD, Harlan Robins, PhD, Christopher S Carlson, PhD, Mark Rieder

Blood (2013) 122 (21): 3480.

https://doi.org/10.1182/blood.V122.21.3480.3480

Published: 2013

Journal Articles

Frequency Of Gene Usage and Copy Number Variation Within The Rearranged Immunoglobin Heavy-Chain Variable Locus Based On Immune Repertoire Sequencing

Mark J. Rieder, PhD, David Williamson, PhD, Anna Sherwood, PhD, Ryan O. Emerson, PhD, Cindy Desmarais, PhD, Moon Chung, Harlan Robins, PhD, Christopher S. Carlson, PhD

Blood (2013) 122 (21): 3486.

https://doi.org/10.1182/blood.V122.21.3486.3486

Published: 2013

Journal Articles

Detection Of Recurrent/Persistent Disease By T-Cell Receptor Repertoire Profiling In Patients With Mature T-Cell Neoplasm

Anna Sherwood, PhD, Harlan Robins, PhD, Jonathan R. Fromm, MD, PhD, Harvey A. Greisman, MD, PhD, Daniel E. Sabath, MD, PhD, Ryan O. Emerson, PhD, Mark J. Rieder, PhD, Brent L. Wood, MD, PhD, David Wu, MD, PhD

Blood (2013) 122 (21): 2614.

https://doi.org/10.1182/blood.V122.21.2614.2614

Published: 2013

Journal Articles

On-Going Evolution Of IGH In B-Cell Precursor Acute Lymphoblastic Leukemia Does Not Substantially Affect Day 29, Post-Treatment MRD Quantification By High-Throughput Sequencing

Blood (2013) 122 (21): 1341.

https://doi.org/10.1182/blood.V122.21.1341.1341

Published: 2013

Journal Articles

Assessing B Lymphocyte Clonal Diversity, Expansion, and Convergent Evolution By High-Throughput Sequencing Of Rearranged IGH Segments From Naïve and Memory Repertoires

William S DeWitt, III, Paul Lindau, Ryan O Emerson, PhD, Anna Sherwood, PhD, David Williamson, PhD, Mark J Rieder, PhD, Moon Chung, Christopher S Carlson, PhD, Harlan Robins, PhD

Blood (2013) 122 (21): 1045.

https://doi.org/10.1182/blood.V122.21.1045.1045

Published: 2013

Journal Articles

Immune Profiling Suggests an IGH Signaling-Dependent Subtype of Aggressive B-ALL

Christopher S Carlson, PhD, Michael A. Pulsipher, MD, Bryan Langholz, PhD, Anna Sherwood, PhD, Cindy Desmarais, PhD, Harlan Robins, PhD, Michael Kalos, PhD, Stephan A. Grupp, MD, PhD

Blood (2012) 120 (21): 1428.

https://doi.org/10.1182/blood.V120.21.1428.1428

Published: 2012

Journal Articles

T Cell Repertoire Diversity After Umbilical Cord Transplant Predicts Mortality From Infection

Colleen Delaney, MD, MSc, Ryan O Emerson, PhD, Filippo Milano, MD, PhD, Anna Sherwood, PhD, Adrienne Papermaster, Katherine A. Guthrie, PhD, Christopher S Carlson, PhD, Edus H. Warren, III, MD, PhD, Harlan Robins, PhD

Blood (2012) 120 (21): 4202.

https://doi.org/10.1182/blood.V120.21.4202.4202

Published: 2012

Journal Articles

High-Throughput Sequencing of T-Cell Receptor Gene Loci for Minimal Residual Disease Monitoring in T Lymphoblastic Leukemia

David Wu, MD, PhD, Anna Sherwood, PhD, Stuart S. Winter, MD, Kimberly Dunsmore, MD, Mignon L Loh, MD, Jonathan R Fromm, MD, PhD, Harvey A Greisman, MD, PhD, Daniel E. Sabath, MD, PhD, Brent L. Wood, MD, PhD, Harlan Robins, PhD

Blood (2011) 118 (21): 2545.

https://doi.org/10.1182/blood.V118.21.2545.2545

Published: 2011

NARROW

Large-Scale Post-Transplant TCR Deep Sequencing Reveals a Major T Cell Diversity Bottleneck with Post-Transplant Cyclophosphamide with Implications for Both Efficacy and Toxicity: Results of the BMT CTN 1801 Study

Molecular Detection of Minimal Residual Disease Precedes Morphological Relapse and Could be Used to Identify Relapse in Pediatric and Young Adult B-Cell Acute Lymphoblastic Leukemia Patients Treated with Tisagenlecleucel

Measurable residual disease detection by high-throughput sequencing improves risk stratification for pediatric B-ALL

Day 90 Post-Allogeneic Hematopoietic Cell Transplantation T Cell Receptor Diversity Level Correlates with Risk of Relapse in Patients with Multiple Myeloma

Residual Disease Monitoring By High Throughput Sequencing Provides Risk Stratification in Childhood B-ALL and Identifies a Novel Subset of Patients Having Poor Outcome

Integrated Immunological Analysis of the Bone Marrow Tumor Microenvironment in Myeloproliferative Neoplasms to Determine Potential Efficacy of Immune Checkpoint Blockade

A Complementary Role of High Throughput Sequencing and Multiparameter Cytometry for Minimal Residual Disease (MRD) Detection in Chronic Lymphocytic Leukemia (CLL):an European Research Initiative (ERIC) Study

Minimal Residual Disease Detection By Next Generation Sequencing in Adult B-Cell Acute Lymphoblastic Leukemia (ALL) Patients Treated on SWOG Trial S0333

High Throughput TCR Sequencing Provides Added Value in the Diagnosis of Cutaneous T-Cell Lymphoma

TCR Repertoire Diversity Assessed with Immunosequencing Is Associated with Patient Mortality Following Cord Blood Transplant

Robust Detection Of Minimal Residual Disease In Unselected Patients With B-Cell Precursor Acute Lymphoblastic Leukemia By High-Throughput Sequencing Of IGH

Reduction Of Immune Repertoire Diversity Through DNA Sequence Constraints At VDJ Junctions

Annotation Of Pseudogenous Gene Segments By Massively Parallel Sequencing Of Rearranged Lymphocyte Receptor Loci

Frequency Of Gene Usage and Copy Number Variation Within The Rearranged Immunoglobin Heavy-Chain Variable Locus Based On Immune Repertoire Sequencing

Detection Of Recurrent/Persistent Disease By T-Cell Receptor Repertoire Profiling In Patients With Mature T-Cell Neoplasm

On-Going Evolution Of IGH In B-Cell Precursor Acute Lymphoblastic Leukemia Does Not Substantially Affect Day 29, Post-Treatment MRD Quantification By High-Throughput Sequencing

Assessing B Lymphocyte Clonal Diversity, Expansion, and Convergent Evolution By High-Throughput Sequencing Of Rearranged IGH Segments From Naïve and Memory Repertoires

Immune Profiling Suggests an IGH Signaling-Dependent Subtype of Aggressive B-ALL

T Cell Repertoire Diversity After Umbilical Cord Transplant Predicts Mortality From Infection

High-Throughput Sequencing of T-Cell Receptor Gene Loci for Minimal Residual Disease Monitoring in T Lymphoblastic Leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only